Literature DB >> 31693250

Hemodynamics of concomitant tricuspid valve procedures at LVAD implantation.

Teruhiko Imamura1, Nikhil Narang1, Jerry Nnanabu1, Daniel Rodgers1, Jayant Raikhelkar1, Sara Kalantari1, Bryan Smith1, Ann Nguyen1, Ben Chung1, Takeyoshi Ota2, Tae Song2, Valluvan Jeevanandam2, Gene Kim1, Gabriel Sayer1, Nir Uriel1.   

Abstract

BACKGROUND: Tricuspid regurgitation (TR) is common in patients receiving left ventricular assist device (LVAD) implantation. The current literature is conflicting regarding the effects of concomitant tricuspid valve repair (TVR) at LVAD implantation. We investigated the hemodynamic effects of concomitant TVR at LVAD implantation.
METHODS: Consecutive clinically stable LVAD outpatients who underwent hemodynamic ramp testings were enrolled in this study, and they were stratified by concomitant TVR. Results of hemodynamic ramp tests were compared between the TVR group and the non-TVR group.
RESULTS: Among 65 LVAD patients undergoing ramp tests, 34 patients had received TVR, and 31 had not. There were no significant differences in baseline characteristics between two groups except for higher degree of TR and lower pulmonary artery pulsatility index in the TVR group (P < .05 for both). Following LVAD implantation, the degree of TR improved significantly in the TVR group down to the comparable level with the non-TVR group. During ramp tests, the TVR group had steeper cardiac index slope (0.14 ± 0.12 vs 0.07 ± 0.07 L/min/m2 /step, P = .002) and higher cardiac index at set LVAD speed (2.99 ± 0.84 vs 2.52 ± 0.42 L/min/m2 , P = .007).
CONCLUSIONS: Concomitant TVR improves cardiac output and its response to LVAD speed change following LVAD implantation. Longitudinal clinical implications of such hemodynamic changes are unknown.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  heart failure; right ventricular failure; tricuspid regurgitation

Mesh:

Year:  2019        PMID: 31693250      PMCID: PMC7135914          DOI: 10.1111/jocs.14275

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  24 in total

1.  Surgical treatment of tricuspid valve insufficiency promotes early reverse remodeling in patients with axial-flow left ventricular assist devices.

Authors:  Simon Maltais; Yan Topilsky; Vakhtang Tchantchaleishvili; Stephen H McKellar; Lucian A Durham; Lyle D Joyce; Richard C Daly; Soon J Park
Journal:  J Thorac Cardiovasc Surg       Date:  2011-08-11       Impact factor: 5.209

2.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Rick A Nishimura; Catherine M Otto; Robert O Bonow; Blase A Carabello; John P Erwin; Robert A Guyton; Patrick T O'Gara; Carlos E Ruiz; Nikolaos J Skubas; Paul Sorajja; Thoralf M Sundt; James D Thomas
Journal:  J Am Coll Cardiol       Date:  2014-03-03       Impact factor: 24.094

3.  Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.

Authors:  Ulas Höke; Dominique Auger; Joep Thijssen; Ron Wolterbeek; Enno T van der Velde; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Heart       Date:  2014-01-21       Impact factor: 5.994

4.  Tumor necrosis factor-α levels and non-surgical bleeding in continuous-flow left ventricular assist devices.

Authors:  Corey E Tabit; Mitchell J Coplan; Phetcharat Chen; Valluvan Jeevanandam; Nir Uriel; James K Liao
Journal:  J Heart Lung Transplant       Date:  2017-06-08       Impact factor: 10.247

5.  Determinants of functional tricuspid regurgitation in incomplete tricuspid valve closure: Doppler color flow study of 109 patients.

Authors:  A Sagie; E Schwammenthal; L R Padial; J A Vazquez de Prada; A E Weyman; R A Levine
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

6.  Limited Utility of Tricuspid Valve Repair at the Time of Left Ventricular Assist Device Implantation.

Authors:  Howard K Song; Jill M Gelow; James Mudd; Christopher Chien; Frederick A Tibayan; Kathryn Hollifield; David Naftel; James Kirklin
Journal:  Ann Thorac Surg       Date:  2016-04-30       Impact factor: 4.330

7.  Hemodynamic Ramp Tests in Patients With Left Ventricular Assist Devices.

Authors:  Nir Uriel; Gabriel Sayer; Karima Addetia; Savitri Fedson; Gene H Kim; Daniel Rodgers; Eric Kruse; Keith Collins; Sirtaz Adatya; Nitasha Sarswat; Ulrich P Jorde; Colleen Juricek; Takeyoshi Ota; Valluvan Jeevanandam; Daniel Burkhoff; Roberto M Lang
Journal:  JACC Heart Fail       Date:  2015-12-30       Impact factor: 12.035

8.  Impact of continuous-flow left ventricular assist device support on right ventricular function.

Authors:  Jeffrey A Morgan; Gaetano Paone; Hassan W Nemeh; Raghav Murthy; Celeste T Williams; David E Lanfear; Cristina Tita; Robert J Brewer
Journal:  J Heart Lung Transplant       Date:  2013-02-09       Impact factor: 10.247

9.  Impact of tricuspid regurgitation on long-term survival.

Authors:  Jayant Nath; Elyse Foster; Paul A Heidenreich
Journal:  J Am Coll Cardiol       Date:  2004-02-04       Impact factor: 24.094

10.  Durability of De Vega tricuspid valve annuloplasty for severe tricuspid regurgitation during left ventricular assist device implantation.

Authors:  Shahab A Akhter; M Reza Salabat; Jennifer L Philip; Tracy B Valeroso; Mark J Russo; Jonathan D Rich; Valluvan Jeevanandam
Journal:  Ann Thorac Surg       Date:  2014-05-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.